Patent · US Active

Antibody specifically binding to insulin-like growth factor-1

US9273144B2 · kind B2 · utility

1Cited by

2References

1Claims

0Family size

Assignee

Roche Diagnostics Operations, Inc. · US

Inventors

Herbert Andres · Penzberg, DE
Hartmut Duefel · Schlehdorf, DE
Michael Gerg · Munich, DE
Frank Kowalewsky · Munich, DE
Christian Scholz · Penzberg, DE
Michael Schraeml · Penzberg, DE

Key dates

Filing date	Nov 1, 2013
Grant date	Mar 1, 2016
Priority date	—
Expiry date	Nov 1, 2033

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/99
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Isolated antibodies that specifically bind to an epitope comprised in the stretch of amino acids ranging from amino acid 76 to amino acid 84 of human insulin-like growth factor-1 precursor (SEQ ID NO:1). Use of the novel antibodies for the sensitive and specific detection of insulin-like growth factor-1, in some embodiments while in the presence of high excess concentration of insulin-like growth factor-2, for example in a bodily fluid sample.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.